Total Payments
$8,988
2024 Payments
$1,584
Companies
40
Transactions
441
Medicare Patients
13,383
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$8,068 (89.8%)
Travel$612.40 (6.8%)
Education$307.33 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,068 | 434 | 89.8% |
| Travel and Lodging | $612.40 | 1 | 6.8% |
| Education | $307.33 | 6 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,873 | 120 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,464 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,230 | 64 | $0 (2024) |
| Veran Medical Technologies, Inc. | $793.69 | 4 | $0 (2018) |
| Grifols USA, LLC | $462.54 | 24 | $0 (2023) |
| GENZYME CORPORATION | $353.47 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $294.00 | 14 | $0 (2024) |
| Genentech USA, Inc. | $269.86 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $198.00 | 2 | $0 (2017) |
| Paratek Pharmaceuticals, Inc. | $166.38 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,584 | 76 | GlaxoSmithKline, LLC. ($463.12) |
| 2023 | $1,539 | 74 | GlaxoSmithKline, LLC. ($434.54) |
| 2022 | $1,341 | 74 | GlaxoSmithKline, LLC. ($407.77) |
| 2021 | $1,203 | 76 | GlaxoSmithKline, LLC. ($299.51) |
| 2020 | $278.64 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($71.32) |
| 2019 | $842.39 | 47 | Boehringer Ingelheim Pharmaceuticals, Inc. ($216.33) |
| 2018 | $1,413 | 39 | Veran Medical Technologies, Inc. ($758.47) |
| 2017 | $786.70 | 38 | Astellas Pharma US Inc ($198.00) |
All Payment Transactions
441 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $7.52 | General |
| Category: Narcoplepsy | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.40 | General |
| Category: Narcoplepsy | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $5.93 | General |
| Category: Narcoplepsy | ||||||
| 09/18/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Airway Clearance Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,735 | 4,152 | $500,715 | $258,351 |
| 2022 | 22 | 2,994 | 4,695 | $532,055 | $274,582 |
| 2021 | 20 | 3,270 | 5,258 | $594,916 | $316,008 |
| 2020 | 24 | 4,384 | 6,638 | $747,176 | $406,579 |
Total Patients
13,383
Total Services
20,743
Medicare Billing
$1.3M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 258 | 809 | $80,940 | $46,507 | 57.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 368 | 489 | $61,805 | $43,068 | 69.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 128 | 401 | $56,140 | $34,649 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 477 | 520 | $57,216 | $30,485 | 53.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 193 | 208 | $50,584 | $25,899 | 51.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 233 | 599 | $35,940 | $21,463 | 59.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $17,736 | $10,766 | 60.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 96 | 105 | $20,475 | $9,966 | 48.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 50 | $9,553 | $6,420 | 67.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 72 | 73 | $21,900 | $5,888 | 26.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 67 | 70 | $21,350 | $5,793 | 27.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 36 | 41 | $20,623 | $3,308 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 60 | 68 | $7,480 | $2,943 | 39.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 15 | $5,850 | $2,405 | 41.1% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 16 | 23 | $8,800 | $1,876 | 21.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 169 | 171 | $3,420 | $1,452 | 42.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 169 | 171 | $6,840 | $1,221 | 17.8% |
| 94660 | Therapy procedure using a positive pressure ventilator | Facility | 2023 | 43 | 44 | $7,480 | $1,178 | 15.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $1,890 | $1,152 | 60.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 169 | 171 | $2,551 | $1,074 | 42.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 17 | 17 | $2,142 | $839.60 | 39.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 324 | 933 | $93,300 | $50,158 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 374 | 519 | $65,595 | $45,888 | 70.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 531 | 631 | $69,458 | $38,623 | 55.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 134 | 441 | $61,740 | $33,582 | 54.4% |
About Dr. Rohit Patel, M.D
Dr. Rohit Patel, M.D is a Pulmonary Disease healthcare provider based in Anniston, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023099587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rohit Patel, M.D has received a total of $8,988 in payments from pharmaceutical and medical device companies, with $1,584 received in 2024. These payments were reported across 441 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,068).
As a Medicare-enrolled provider, Patel has provided services to 13,383 Medicare beneficiaries, totaling 20,743 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Anniston, AL
- Active Since 11/10/2005
- Last Updated 02/03/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1023099587
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,229
- Spin (Device) $793.69
- DUPIXENT (Biological) $629.37
- STIOLTO RESPIMAT (Drug) $602.70
- Prolastin-C Liquid (Biological) $445.54
- FASENRA (Biological) $417.63
- NUCALA (Biological) $389.61
- STIOLTO (Drug) $335.09
- Xolair (Biological) $281.46
- OFEV (Drug) $231.99
- BREZTRI (Drug) $198.06
- SPIRIVA RESPIMAT (Drug) $177.31
- FASENRA (Drug) $173.30
- NUZYRA (Drug) $166.38
- SYMBICORT (Drug) $165.98
- TEZSPIRE (Biological) $148.49
- GLASSIA (Biological) $146.29
- AREXVY (Drug) $143.40
- VIBATIV (Drug) $97.80
- Wakix (Drug) $96.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.